We studied the central hemodynamic, leg blood flow, and metabolic responses to maximal upright bicycle exercise in 30 patients with chronic heart failure attributable to severe left ventricular dysfunction (ejection fraction, 24+8%) Hg, p<0.01) compared with normal subjects. Leg blood flow was decreased in patients versus normal subjects at rest and matched submaximal work rates and maximal exercise (2.1±1.9 vs. 6.4±1.4 1/min, all p<0.01). Mean systemic arterial blood pressure was no different in the two groups at rest or at matched submaximal work rates, whereas leg vascular resistance was higher in patients compared with normal subjects at rest, submaximal, and maximal exercise (all p<0.01). Although nonleg blood flow was decreased at rest in patients, it did not decrease significantly during exercise in either group. Peak exercise leg blood flow was related to peak exercise cardiac output in patients (r=0.66, p<0.01) and normal subjects (r=0.67, p<0.01). In patients, leg vascular resistance was not related to mean arterial blood pressure, pulmonary capillary wedge pressure, arterial catecholamines, arterial lactate, or femoral venous pH at rest or during exercise. Compared with normal subjects during submaximal exercise, patients demonstrated increased leg oxygen extraction and lactate production accompanied by decreased leg oxygen consumption. Thus, in patients with chronic heart failure compared with normal subjects, skeletal muscle perfusion is decreased at rest and during submaximal and maximal exercise, and local vascular resistance is increased. Our data indicate that nonleg blood flow and arterial blood pressure were preferentially maintained during exercise at the expense of leg hypoperfusion in our patients. This was associated with decreased leg oxygen utilization and increased leg oxygen extraction when compared to normal subjects, providing further evidence that reduced perfusion of skeletal muscle is important in causing early anaerobic skeletal muscle metabolism during exercise in subjects with this disorder. Although these results do not define the mechanisms responsible for increased leg vascular resistance during exercise in subjects with chronic heart failure, our finding that arterial blood pressure in patients was closely regulated suggests a role for reflex-mediated peripheral vasoconstriction in linking the cardiac output and skeletal muscle blood flow responses to exercise in subjects with this disorder. (Circulation 1989;80:769-781) E 5 xercise intolerance is a major cause of mormuscle anaerobic metabolism,1-4 not increased pulbidity in patients with chronic heart failure. monary capillary wedge pressure, is the primary Recent studies indicate that early skeletal factor limiting exercise performance in stable ambu-
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Circulation Vol 80, No 4, October 1989 latory patients with this disorder. Decreased perfusion of skeletal muscle during exercise is known to be a powerful stimulus for early anaerobic metabolism5-7 and has been demonstrated by numerous investigators over the past two decades in patients with chronic heart failure. 8 14 However, the pathophysiologic basis of decreased muscle blood flow during isotonic exercise in subjects with this disorder has not been clearly defined. Wilson et al '5 have suggested that relative arterial hypotension may be an important factor in reducing peripheral blood flow in patients with this disorder, and studies have demonstrated that hypotension is an important factor reducing muscle blood flow in animal models of heart failure. 16, 17 In contrast, studies by Zelis et all8 have demonstrated that the vasodilator response to a number of stimuli is reduced in patients with heart failure, suggesting that intrinsic abnormalities in limb vasodilator capacity are responsible for peripheral blood flow abnormalities. Thus, the relative roles of increased vascular resistance and arterial hypotension in causing skeletal muscle hypoperfusion during isotonic exercise involving large muscle groups in patients with chronic heart failure have not been clearly defined. This distinction may have important therapeutic implications because vasodilator therapy may cause a worsening of hypotension and, therefore, may actually decrease peripheral blood flow during exercise in some patients with chronic heart failure, which may influence the variable clinical response to vasodilator therapy in this disorder. '5 However,  several studies suggest that improvements in peripheral vascular conductance, not changes in arterial blood pressure, are important in determining the long-term response to vasodilators19 or exercise training20 in subjects with this disorder.
See p 1084 The present study was designed to determine the central hemodynamic, metabolic, neurohumoral, and leg blood flow (LBF) responses to maximal upright bicycle exercise in patients with chronic heart failure and to compare these results with data obtained from identical testing in a group of normal volunteers. The study was designed to determine the relative roles of arterial hypotension and increased leg vascular resistance in determining LBF abnormalities, and to examine the distribution of cardiac output during exercise in patients with this disorder.
Methods

Patient Group
Thirty-two men and one woman with New York Heart Association functional Classes I-IV congestive heart failure participated in the study. Due to technical difficulties, three male patients did not have LBF measurements and were excluded from analysis. Of the 30 patients studied, three had New York Heart Association functional Class I, 12 had functional Class II, 11 had functional Class III, and four patients had functional Class IV heart failure. All subjects had heart failure on the basis of severe left ventricular dysfunction (ejection fraction, 24+8%; range, 8-36%); 22 had coronary artery disease and eight had idiopathic dilated cardiomyopathy. All subjects were limited by dyspnea or fatigue during maximal exercise testing, and no patient had pulmonary rales, claudication, or peripheral bruits; 10 patients had mild pedal edema. Twenty-four of the patients had stable symptoms for 2 months before study; six patients had increasing symptoms over the previous 2 months but were stabilized for 72 hours prior to study. Twenty-eight patients were taking digoxin, and 29 were taking diuretics. Five patients with severe symptoms (four Class IV and one Class III) were unable to be withdrawn from chronic vasodilator therapy (captopril, n=3; nitrates, n=2) prior to study. Four patients were engaged in regular aerobic exercise prior to study.
Normal Subjects
Twelve men with normal medical histories and physical examinations who were on no medications volunteered to serve as control subjects. All had a normal electrocardiographic response on a screening maximal bicycle exercise test. Three subjects were engaged in regular aerobic exercise.
Study Protocol
All studies were performed under a research protocol approved by the Institutional Review Boards at both the Duke University and Durham Veterans Administration Medical Centers. Twentyeight patients and all normal subjects underwent a familiarization maximal bicycle exercise test with expired gas analysis 2-14 days prior to the study; two patients did not. Patients were given their usual cardiac medications 3 hours before testing, which was usually at 11:00 A.M. Exercise studies were performed using an isokinetic bicycle at least 2 hours after subjects had eaten. All subjects performed graded exercise with the work rate beginning at 150 kilopond meters (kpm)/min and advancing in 3-minute stages of 150 kpm/min to a symptom-limited maximum. Heart rate was monitored by electrocardiography, and arterial blood pressure was measured by a sphygmomanometer during the familiarization study and by direct intra-arterial pressure recording in all subjects during the hemodynamic study. Expired gases were continuously analyzed in our laboratory using a Sensormedics (Anaheim, California) 4400 breath-by-breath unit as previously described.20,21 Central Hemodynamics Twenty-five patients and 10 normal subjects had a 7F Swan-Ganz catheter positioned in the right pulmonary artery via an antecubital vein, and all subjects had a femoral venous catheter and a brachial artery cannula inserted 1 hour before exercise. Pulmonary and systemic arterial pressures were recorded continuously, and pulmonary capillary wedge pressure was recorded intermittently at rest and at each workload using Hewlett-Packard transducers, amplifiers, and recorders (Andover, Massachusetts) as previously described.20,21 At rest and in the third minute of each workload, blood samples were taken and were immediately chilled in an ice bath. Oxygen content and saturation of arterial, femoral venous, and mixed venous blood samples were measured on a calibrated Instruments Laboratory 282 cooximeter. Arterial and femoral venous blood lactate concentrations were determined with a Calbiochem-Behring rapid lactate kit (San Diego, California). Blood catecholamine levels were determined at rest, submaximal (300 kpm/min), and maximal exercise in arterial samples of 12 patients using high-pressure liquid chromatography.22 From 12 normal subjects and 18 patients, arterial and femoral venous blood was drawn for measurement of pH (Instruments Laboratory, model 1303, Lexington, Massachusetts).
Leg Blood Flow
In all subjects, LBF was measured with a thermodilution catheter (model 93 A-105-5F, Edwards Laboratory, Santa Ana, California) inserted in the femoral vein 2 cm below the inguinal ligament with the distal thermistor tip positioned 10-12 cm above the inguinal ligament under fluoroscopic guidance as previously described. 20 The catheter was interfaced with a Gould Statham SP 1435 cardiac output computer (Oxnard, California), and bolus injections of 1-6 ml iced or room temperature saline were used to obtain 2-4 blood flow measurements at rest and in the last 90 seconds of each work rate (which were then averaged). Thermodilution (Figure 4 , Panel B) was elevated at rest and during exercise in patients compared to normal subjects. Femoral AVo2 difference ( Figure  4 , Panel C) was increased at rest and during submaximal exercise but was normal at peak exercise in patients. The slope of the increase in femoral AVo2 difference versus work rate was not different in the two groups. Single leg Vo2 (Figure 4 , Panel D) was no different in the two groups at rest but was decreased at submaximal and maximal exercise in patients compared with normal subjects. The slope of the increase in leg Vo2 versus work rate was also decreased in patients compared to normal subjects. Femoral venous oxygen content and femoral venous oxygen saturation were decreased at rest and during submaximal exercise in patients but were not different from those of normal subjects at maximal exercise ( Figure 4 , Panels E and F). Metabolic Response to Exercise Table 2 illustrates arterial catecholamines in patients and arterial and femoral venous pH in patients and normal subjects. Arterial norepinephrine was increased in patients at rest compared with normal upright values and further increased during exercise. Arterial pH in patients versus normal subjects was increased at rest and during exercise.
Femoral venous pH was similar in the two groups at rest but was decreased in patients compared to normal subjects at 300 kpm/min. Despite no difference in peak respiratory exchange ratios in the two groups, peak femoral venous pH was higher and peak arterial and femoral venous lactates ( Figure 5 , Panels A and B) were lower in patients than in normal subjects. There were no differences between To examine the effects of vasodilator therapy on the relative distribution of cardiac output, we compared the hemodynamic responses of the five patients taking vasodilators to the six patients with the most severe symptoms selected from those patients taking digoxin and diuretics who were matched for reduced peak Vo2 (Table 3 ). There was no difference in mSAP or %LBF at rest or during submaximal exercise in the two groups, although peak mSAP was reduced in patients on vasodilators. The slope of LBF/cardiac output was no different in Peak Vo2 was closely related to peak LBF in patients (r=0.81, p<0.01) and in normal subjects (r=0.82, p<0.01) (Figure 8 , Panel A), as was peak cardiac output in both patients (r=0.88, p<0.001) and normal subjects (r=0.82, p<0.001) (Figure 8 , Panel B). In patients, peak LBF was related to peak cardiac output (r=0.66, p<0.001), and peak LVR was inversely related to both peak cardiac output (r= -0.53,p <0.01) and peak Vo2 (r=-0.60,p<0.01). In normal subjects, peak LBF was related to peak cardiac output (r=0.67, p<0.01), and peak LVR was related to peak Vo2 (r= -0.78, p<0.001) and peak cardiac output (r=-0.76, p<0.001). In both patients and normal subjects, LBF and LVR at rest, submaximal (300 kpm/min), and maximal exercise were not closely related (all r2<0.2, p>O0.03) to the corresponding values for arterial lactate, arterial norepinephrine or epinephrine, pulmonary capillary wedge pressure, or mSAP. Femoral venous pH was unrelated to LBF in patients at rest or during PEAK EXERCISE V02 (mil/min) submaximal exercise, but was related to peak LBF in normal subjects (r=-0.74,p<0.01).
Discussion The present study demonstrates that in patients with chronic heart failure, LBF was reduced and LVR was increased at rest and during exercise compared to normal subjects. Our results are consistent with previous studies of patients with this disorder,8,9,13 demonstrating that skeletal muscle perfusion was reduced compared to normal subjects during isotonic exercise involving large muscle groups. We extend these observations by demonstrating that arterial hypotension is not the primary mechanism causing peripheral blood flow abnormalities in stable patients with chronic heart failure. Although previous studies have defined abnormalities in the baroreceptor response to a number of stimuli in the heart failure state,25,26 our patients demonstrated a normal blood pressure response to the complex physiologic challenge of upright isotonic exercise. Although the results of the present study do not define the specific mechanisms responsible for reduced LBF in subjects with this disorder, our data suggest that stable patients with chronic heart failure preferentially maintain arterial perfusion pressure and blood flow to nonexercising regions at the expense of leg hypoperfusion during exercise.
Previous studies by Leithe et the importance of intrinsic vasodilator abnormalities in increasing leg vascular resistance in subjects with this disorder, our finding that arterial blood pressure was closely regulated in patients suggests that LVR is determined, in part, by dynamic alterations in leg vasomotor tone during exercise.
The present study is one of the first to measure cardiac output and LBF during maximal graded exercise in normal subjects.37,38 Our finding that the slope of the increase in single LBF versus cardiac output was 0.52+0.08 in normal subjects is consistent with the concept, derived mainly from animal studies, that increments in cardiac output during exercise are directed primarily to working skeletal muscle in man. As described in previous studies,37-39 LBF increased linearly in relation to work rate in our normal subjects and did not plateau during submaximal exercise. At the onset of exercise, LVR decreased markedly in both patients and normal subjects and then decreased more gradually as the exercise intensity increased. Thus, increases in LBF were dependent on increases in mSAP during moderate and severe exercise by both groups. Although patients in the present study did not demonstrate arterial hypotension during exercise, our results do not exclude the possibility that arterial hypotension may play a role in reducing skeletal muscle blood flow during exercise in unstable patients with more severe heart failure or in patients who develop hypotension while initiating vasodilator therapy.
NLF calculated as: cardiac output-(LBFx2), represents flow to both nonexercising regions (visceral organs, brain) and exercising regions (trunk and respiratory muscles, heart). Therefore, changes in this variable during exercise likely represent increases in flow to exercising regions and decreases in flow to splanchnic and renal beds, with variable changes in skin blood flow.24 Although the distribution of cardiac output to individual organs during exercise was not determined in the present study, our finding that NLF was maintained in patients during exercise is consistent with the concept of Zelis et al14 that intense skeletal muscle vasoconstriction during exercise in patients with chronic heart failure may prevent hypoperfusion and, possibly, ischemia in vital nonexercising regions.
Zelis et al10'1' have previously reported an attenuation in oxygen uptake during forearm exercise in patients with chronic heart failure. Our findings demonstrate a similarly reduced limb Vo2 in patients compared to normal subjects, during both submaximal and maximal leg exercise, and indicate that this occurred despite an increase in oxygen extraction during submaximal exercise. Although previous studies have suggested that skeletal muscle metabolic abnormalities are present in patients with chronic heart failure,40-42 our data indicate that peripheral oxygen utilization in subjects with this disorder is limited partly by hypoperfusion. However, our patients did not demonstrate maximal leg AVo2 differences that were higher than those seen in normal subjects. In contrast, an increase in leg oxygen extraction at peak exercise has previously been demonstrated in patients with leg hypoperfusion due to claudication. 5 Hansen et a143 and Koike et al4 have demonstrated that patients with cardiac dysfunction have a reduced systemic Vo2 to work rate relation compared to normal subjects. The present study has demonstrated a similar reduction in the systemic Vo2 to work rate relation in patients with chronic heart failure. Our finding that leg Vo2 during exercise was also decreased in patients compared to normal subjects suggests that the reduced systemic Vo2 to work rate relation was directly attributable to decreased oxygen delivery to working skeletal muscle.
Our patients demonstrated an accelerated rise in blood lactate levels during exercise, which has previously been described by Weber et al3'45 and Wilson et al2'8 for similar patient groups. The present study extends these observations by demonstrating that increased blood lactate levels in patients were associated with markedly increased skeletal muscle lactate production. This finding suggests that reduced lactate clearance is not the primary mechanism responsible for increased blood lactate concentrations in patients, and is consistent both with 31P-NMR studies demonstrating accelerated intramuscular acidosis28'29 and with exerciseskeletal-muscle biopsy studies in our laboratory46 demonstrating increased intramuscular lactate content during submaximal exercise in patients with this disorder. Although intrinsic abnormalities in skeletal muscle histology and biochemistry40-42 and heightened adrenergic stimulation may play an important role in determining the metabolic response to exercise in subjects with this disorder, our finding that leg Vo2 was decreased and leg lactate production was increased supports the concept that skeletal muscle hypoperfusion during exercise contributes to early anaerobic metabolism in subjects with this disorder. 
